Uroflow Measurements in Urogynecology Patients Compared to Healthy Female Volunteers

This study has been completed.
Sponsor:
Information provided by:
University of Rochester
ClinicalTrials.gov Identifier:
NCT00919048
First received: June 10, 2009
Last updated: December 15, 2009
Last verified: December 2009
  Purpose

To compare uroflowmetry measurements of patients undergoing urodynamic testing as part of an incontinence work-up in an urogynecology practice to healthy female volunteers.


Condition
Urogynecology

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Uroflow Measurements in Urogynecology Patients Compared to Healthy Female Volunteers

Further study details as provided by University of Rochester:

Primary Outcome Measures:
  • Voiding variables of patients will be compared to those of healthy female volunteers collected from another study. [ Designated as safety issue: No ]

Estimated Enrollment: 36
Study Start Date: September 2008
Study Completion Date: September 2008
Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
Urodynamic patients
Uroflow studies of patients who underwent urodynamics as part of an incontinence work-up.

  Eligibility

Ages Eligible for Study:   25 Years to 60 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Urogynecology clinic

Criteria

Inclusion Criteria:

  • All patients who underwent urodynamics at the urogynecology clinic during the past 12 months
  • Voids larger than 50 mls.

Exclusion Criteria:

  • History of pelvic organ prolapse, incomplete bladder emptying, and voids less than 50cc.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00919048

Locations
United States, New York
University of Rochester
Rochester, New York, United States, 14642
Sponsors and Collaborators
University of Rochester
Investigators
Principal Investigator: Gunhilde Buchsbaum, MD University of Rochester
  More Information

No publications provided

Responsible Party: Gunhilde Buchsbaum, MD, University of Rochester
ClinicalTrials.gov Identifier: NCT00919048     History of Changes
Other Study ID Numbers: 25597
Study First Received: June 10, 2009
Last Updated: December 15, 2009
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on July 22, 2014